Kenneth R Chien

This inventor holds 30 USPTO granted patents and 13 published patent applications and 6 EPO patents, primarily in Cardiac Progenitor Cells. Top assignees: University of California, Procella Therapeutics Ab, Genentech, Inc.. Active years: 1996-2025.

USPTO Granted Patents = 30 (Patent Applications = 13)

% Patents Active = 86.7

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 3.4

ph-index = 7

Forward Citations = 247(Granted Patents)

Location History:

La Jolla, CA (US) (1996 - 2010)
Cambridge, MA (US) (2013 - 2023)

Company Filing History:

16 out of 16,008

University of California

patents

8 out of 8

Procella Therapeutics Ab

The General Hospital Corporation

patents

5. 2 out of 1,072

Children's Medical Center Corporation

7. 2 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...

Areas of Expertise:

Cardiac Progenitor Cells

Modified RNA

Diabetes Treatment

Genetic Markers

Vascularized Heart Tissue

Heart Failure

Cardiac Gene Transfer

Cardiac Hypertrophy

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404488 - Use of neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells (2025-09-02),

2. 12357675 - Efficient protein expression in vivo using modified RNA (mod-RNA) (2025-07-15),

3. 11725244 - Genetic markers for engraftment of human cardiac ventricular progenitor cells (2023-08-15),

4. 11401508 - Methods for isolating human cardiac ventricular progenitor cells (2022-08-02),

5. 11186820 - Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells (2021-11-30),

6. 10612094 - Genetic markers for engraftment of human cardiac ventricular progenitor cells (2020-04-07),

7. 10597637 - Use of jagged 1/frizzled 4 as a cell surface marker for isolating human cardiac ventricular progenitor cells (2020-03-24),

8. 10596200 - Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cells (2020-03-24),

9. 10508263 - Methods for isolating human cardiac ventricular progenitor cells (2019-12-17),

10. 10086043 - Efficient protein expression in vivo using modified RNA (MOD-RNA) (2018-10-02),

11. 8765117 - Generation of vascularized human heart tissue and uses thereof (2014-07-01),

12. 8420612 - Diabetes treatment methods and drug targets therefor (2013-04-16),

13. 7745113 - Use of islet 1 as a marker for isolating or generating stem cells (2010-06-29),

14. 7399750 - Methods for cardiac gene transfer (2008-07-15),

15. 7193075 - Sequences upstream of the CARP gene, vectors containing them and uses thereof (2007-03-20),

Title: The Innovative Journey of Kenneth R Chien

Introduction: Kenneth R Chien, a distinguished inventor based in Cambridge, MA, has made significant contributions to the field of biotechnology and medical research through his groundbreaking innovations.

Latest Patents: Kenneth R Chien holds several patents related to cardiac regeneration and stem cell biology, showcasing his commitment to advancing medical treatments for cardiovascular diseases.

Career Highlights: With a career spanning over several decades, Kenneth R Chien has held prominent positions at renowned research institutions and universities, including Harvard University and the Karolinska Institute. His research focuses on understanding the molecular mechanisms underlying heart development and regeneration.

Collaborations: Throughout his career, Kenneth R Chien has collaborated with leading scientists, medical professionals, and biotech companies to further his research in cardiac biology. His collaborative efforts have resulted in pioneering discoveries in the field.

Conclusion: Kenneth R Chien's dedication to innovation and his relentless pursuit of scientific excellence have established him as a prominent figure in the field of biotechnology and medical research. His work continues to inspire future generations of inventors and researchers in the quest for groundbreaking discoveries.